109 related articles for article (PubMed ID: 34929599)
1. SLC34A2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer.
Yang Y; Wu J; Yu X; Wu Q; Cao H; Dai X; Chen H
Pathol Res Pract; 2022 Jan; 229():153706. PubMed ID: 34929599
[TBL] [Abstract][Full Text] [Related]
2. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract][Full Text] [Related]
3. The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer.
Li X; Xing J; Wang H; Yu E
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30038060
[TBL] [Abstract][Full Text] [Related]
4. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of the transmembrane protease serine 3 mRNA level in radioresistant colorectal cancer tissues.
Wen JY; Fang YY; Chen G; He RQ; Huang HQ; Wang RS; Zeng DT; Huang WJ; Qin XG
Biomark Med; 2022 Jun; 16(9):693-715. PubMed ID: 35543030
[No Abstract] [Full Text] [Related]
6. Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.
Ye W; Chen C; Gao Y; Zheng ZS; Xu Y; Yun M; Weng HW; Xie D; Ye S; Zhang JX
Cell Death Dis; 2017 Feb; 8(2):e2581. PubMed ID: 28151475
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness.
Guipponi M; Antonarakis SE; Scott HS
Front Biosci; 2008 Jan; 13():1557-67. PubMed ID: 17981648
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
Zhang D; Qiu S; Wang Q; Zheng J
Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways.
Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ
Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
Wang JY; Jin X; Li XF
Oncol Res; 2018 Jan; 26(1):95-101. PubMed ID: 28409556
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.
Zhang X; Ke X; Pu Q; Yuan Y; Yang W; Luo X; Jiang Q; Hu X; Gong Y; Tang K; Su X; Liu L; Zhu W; Wei Y
Oncotarget; 2016 Mar; 7(12):14569-85. PubMed ID: 26910912
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion.
Li Y; Chen X; Lu H
Oncol Res; 2016 Oct; 24(6):511-519. PubMed ID: 28281971
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells.
Yang W; Wang Y; Pu Q; Ye S; Ma Q; Ren J; Zhong G; Liu L; Zhu W
Mol Med Rep; 2014 Sep; 10(3):1205-14. PubMed ID: 25017204
[TBL] [Abstract][Full Text] [Related]
15. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650/SLC34A2 axis.
Zhao Y; Zhu Z; Shi S; Wang J; Li N
Biomed Pharmacother; 2019 Dec; 120():109457. PubMed ID: 31585300
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro.
Guipponi M; Vuagniaux G; Wattenhofer M; Shibuya K; Vazquez M; Dougherty L; Scamuffa N; Guida E; Okui M; Rossier C; Hancock M; Buchet K; Reymond A; Hummler E; Marzella PL; Kudoh J; Shimizu N; Scott HS; Antonarakis SE; Rossier BC
Hum Mol Genet; 2002 Nov; 11(23):2829-36. PubMed ID: 12393794
[TBL] [Abstract][Full Text] [Related]
18. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.
Wallrapp C; Hähnel S; Müller-Pillasch F; Burghardt B; Iwamura T; Ruthenbürger M; Lerch MM; Adler G; Gress TM
Cancer Res; 2000 May; 60(10):2602-6. PubMed ID: 10825129
[TBL] [Abstract][Full Text] [Related]
19. SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma.
Xu Y; Duan S; Ye W; Zheng Z; Zhang J; Gao Y; Ye S
Thorac Cancer; 2024 May; ():. PubMed ID: 38720472
[TBL] [Abstract][Full Text] [Related]
20. TMPRSS3 is a novel poor prognostic factor for breast cancer.
Rui X; Li Y; Jin F; Li F
Int J Clin Exp Pathol; 2015; 8(5):5435-42. PubMed ID: 26191247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
